UREMIC PRURITUS
Clinical trials for UREMIC PRURITUS explained in plain language.
Never miss a new study
Get alerted when new UREMIC PRURITUS trials appear
Sign up with your email to follow new studies for UREMIC PRURITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Dialysis itch breakthrough: new drug eases suffering in weeks
Symptom relief CompletedThis study tested a drug called difelikefalin in 260 Chinese adults on hemodialysis who had moderate-to-severe itching. Participants received either the drug or a placebo for 12 weeks, with an optional extension. The main goal was to see if the drug reduced itching intensity, mea…
Matched conditions: UREMIC PRURITUS
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated May 26, 2026 09:14 UTC
-
New drug offers hope for dialysis Patients' relentless itching
Symptom relief CompletedThis study tested a drug called MR13A9 for people on dialysis who suffer from severe itching. 247 Japanese adults participated, and the drug was compared to a placebo to see if it safely reduces itch intensity. The goal was to find the right dose and confirm the drug's effects.
Matched conditions: UREMIC PRURITUS
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 09:01 UTC
-
New drug offers hope for dialysis Patients' unbearable itching
Symptom relief CompletedThis study tested a drug called MR13A9 in 178 adults on hemodialysis who had severe itching not caused by other conditions. Participants rated their worst itch daily on a 0-10 scale. The study compared MR13A9 to a placebo to see if it better reduced itching over 4 weeks, then con…
Matched conditions: UREMIC PRURITUS
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC